Literature DB >> 1502479

A model of inflammatory bowel disease induced by 2,4-dinitrofluorobenzene in previously sensitized BALB-c mice.

T Brkić1, M Banić, B Anić, Z Grabarević, I Rotkvić, B Artuković, M Duvnjak, P Sikirić, B Troskot, D E Hernandez.   

Abstract

The aim of this study was to develop a model of inflammatory bowel disease (IBD) induced by colonic application of 2,4-dinitrofluorobenzene in previously sensitized BALB-c mice. During the follow-up period of 30 days we observed ulcerations, haemorrhage, necrosis, and mononuclear infiltration in the colonic mucosa of previously sensitized (experimental) and, to a lesser extent, nonsensitized (control) animals. In addition, the animals in the experimental group developed adhesions, thickening of colonic segments, stenosis, and dilatation of the colon, and some animals also developed megacolon. Oedema, mononuclear infiltration, and superficial ulcerations were observed in the ileum of experimental animals and, to a lesser extent, in the control group. In addition, the animals in the experimental group developed extraintestinal changes in the liver and spleen (that is, pericholangitis and lymphofollicular proliferation). We suggest that this model of IBD may have some value for the study of early pathogenetic mechanisms of IBD and for developing new therapeutic modalities for this condition.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1502479     DOI: 10.3109/00365529208999946

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  6 in total

1.  The pharmacological properties of the novel peptide BPC 157 (PL-10).

Authors:  P Sikiric
Journal:  Inflammopharmacology       Date:  1999       Impact factor: 4.473

2.  Pentadecapeptide BPC 157 interactions with adrenergic and dopaminergic systems in mucosal protection in stress.

Authors:  P Sikirić; B Mazul; S Seiwerth; Z Grabarević; R Rucman; M Petek; V Jagić; B Turković; I Rotkvić; S Mise; I Zoricić; L Jurina; P Konjevoda; M Hanzevacki; M Gjurasin; J Separović; D Ljubanović; B Artuković; M Bratulić; M Tisljar; P Miklić; J Sumajstorcić
Journal:  Dig Dis Sci       Date:  1997-03       Impact factor: 3.199

3.  Effect of azithromycin on acute inflammatory lesions and colonic bacterial load in a murine model of experimental colitis.

Authors:  Sanja Plesko; Marko Banić; Vanda Plecko; Branimir Anić; Tomislav Brkić; Heinzl Renata; Ivo Rotkvić
Journal:  Dig Dis Sci       Date:  2009-11-19       Impact factor: 3.199

4.  Inflammatory bowel disease-like enteritis and caecitis in a senescence accelerated mouse P1/Yit strain.

Authors:  S Matsumoto; Y Okabe; H Setoyama; K Takayama; J Ohtsuka; H Funahashi; A Imaoka; Y Okada; Y Umesaki
Journal:  Gut       Date:  1998-07       Impact factor: 23.059

5.  Changes of CD8+CD28- T regulatory cells in rat model of colitis induced by 2,4-dinitrofluorobenzene.

Authors:  Wen-Bin Xiao; Yu-Lan Liu
Journal:  World J Gastroenterol       Date:  2003-11       Impact factor: 5.742

6.  Effect of cyclosporine in a murine model of experimental colitis.

Authors:  Marko Banić; Branimir Anić; Tomislav Brkić; Neven Ljubicić; Sanja Plesko; Csaba Dohoczky; Damir Erceg; Mladen Petrovecki; Igor Stipancić; Ivo Rotkvić
Journal:  Dig Dis Sci       Date:  2002-06       Impact factor: 3.199

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.